相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。FGFR blockade by pemigatinib treats naive and castration resistant prostate cancer
Paola Chiodelli et al.
CANCER LETTERS (2022)
Molecular mechanisms underlying the development of neuroendocrine prostate cancer
Shiqin Liu et al.
SEMINARS IN CANCER BIOLOGY (2022)
BAP1-Related ceRNA (NEAT1/miR-10a-5p/SERPINE1) Promotes Proliferation and Migration of Kidney Cancer Cells
Rui-ji Liu et al.
FRONTIERS IN ONCOLOGY (2022)
Circular RNA circPOLR2A promotes clear cell renal cell carcinoma progression by facilitating the UBE3C-induced ubiquitination of PEBP1 and, thereby, activating the ERK signaling pathway
Zhipeng Xu et al.
MOLECULAR CANCER (2022)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Dishevelled-1 DIX and PDZ domain lysine residues regulate oncogenic Wnt signaling
Monica Sharma et al.
Oncotarget (2021)
Cistrome analysis of YY1 uncovers a regulatory axis of YY1:BRD2/4-PFKP during tumorigenesis of advanced prostate cancer
Chenxi Xu et al.
NUCLEIC ACIDS RESEARCH (2021)
MiR-195 inhibits the ubiquitination and degradation of YY1 by Smurf2, and induces EMT and cell permeability of retinal pigment epithelial cells
Shu-Hua Fu et al.
CELL DEATH & DISEASE (2021)
The Role of Androgen Receptor Splicing Variant 7 in Predicting the Prognosis of Metastatic Castration-Resistant Prostate Cancer: Systematic Review and Meta-Analysis
Rui-Ji Liu et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2021)
Fyn tyrosine kinase, a downstream target of receptor tyrosine kinases, modulates antiglioma immune responses
Andrea Comba et al.
NEURO-ONCOLOGY (2020)
YAP-Mediated Recruitment of YY1 and EZH2 Represses Transcription of Key Cell-Cycle Regulators
Sany Hoxha et al.
CANCER RESEARCH (2020)
Morphologic, Molecular and Clinical Features of Aggressive Variant Prostate Cancer
Rodolfo Montironi et al.
CELLS (2020)
Lineage plasticity in cancer: a shared pathway of therapeutic resistance
Alvaro Quintanal-Villalonga et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer
Cora N. Sternberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Treatment of Advanced Prostate Cancer
Min Yuen Teo et al.
ANNUAL REVIEW OF MEDICINE, VOL 70 (2019)
YY1 regulates cancer cell immune resistance by modulating PD-L1 expression
Emily Hays et al.
DRUG RESISTANCE UPDATES (2019)
hnRNPM, a potential mediator of YY1 in promoting the epithelial-mesenchymal transition of prostate cancer cells
Tong Yang et al.
PROSTATE (2019)
Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP) model: A good alternative to study PCa progression and chemoprevention approaches
Larissa Akemi Kido et al.
LIFE SCIENCES (2019)
ONECUT2 is a driver of neuroendocrine prostate cancer
Haiyang Guo et al.
NATURE COMMUNICATIONS (2019)
Targeting Wnt/EZH2/microRNA-708 signaling pathway inhibits neuroendocrine differentiation in prostate cancer
Jingxuan Shan et al.
CELL DEATH DISCOVERY (2019)
Yin Yang 1 protein ameliorates diabetic nephropathy pathology through transcriptional repression of TGFβ1
Pan Gao et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Transcription Factor YY1 Promotes Cell Proliferation by Directly Activating the Pentose Phosphate Pathway
Shourong Wu et al.
CANCER RESEARCH (2018)
Cellular plasticity and the neuroendocrine phenotype in prostate cancer
Alastair H. Davies et al.
NATURE REVIEWS UROLOGY (2018)
Frizzled-8 integrates Wnt-11 and transforming growth factor-β signaling in prostate cancer
Virginia Murillo-Garzon et al.
NATURE COMMUNICATIONS (2018)
Global Burden of Urologic Cancers, 1990-2013
Geolani W. Dy et al.
EUROPEAN UROLOGY (2017)
Surrogate Wnt agonists that phenocopy canonical Wnt and β-catenin signalling
Claudia Y. Janda et al.
NATURE (2017)
Biology and evolution of poorly differentiated neuroendocrine tumors
David S. Rickman et al.
NATURE MEDICINE (2017)
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53-and RB1-deficient prostate cancer
Ping Mu et al.
SCIENCE (2017)
Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance
Sheng Yu Ku et al.
SCIENCE (2017)
Emerging Variants of Castration-Resistant Prostate Cancer
Panagiotis J. Vlachostergios et al.
CURRENT ONCOLOGY REPORTS (2017)
Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer
Min Zou et al.
CANCER DISCOVERY (2017)
Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling
Eric G. Bluemn et al.
CANCER CELL (2017)
FZD8, a target of p53, promotes bone metastasis in prostate cancer by activating canonical Wnt/β-catenin signaling
Qiji Li et al.
CANCER LETTERS (2017)
Disrupting Androgen Receptor Signaling Induces Snail-Mediated Epithelial-Mesenchymal Plasticity in Prostate Cancer
Lu Miao et al.
CANCER RESEARCH (2017)
The Initial Detection and Partial Characterization of Circulating Tumor Cells in Neuroendocrine Prostate Cancer
Himisha Beltran et al.
CLINICAL CANCER RESEARCH (2016)
N-cadherin functions as a growth suppressor in a model of K-ras-induced PanIN
Y. Su et al.
ONCOGENE (2016)
N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells
John K. Lee et al.
CANCER CELL (2016)
Global Incidence and Mortality for Prostate Cancer: Analysis of Temporal Patterns and Trends in 36 Countries
Martin C. S. Wong et al.
EUROPEAN UROLOGY (2016)
Acquired resistance to the second-generation androgen receptor antagonist enzalutamide in castration-resistant prostate cancer
Steven Kregel et al.
ONCOTARGET (2016)
Integrative Clinical Genomics of Advanced Prostate Cancer
Dan Robinson et al.
CELL (2015)
Prognostic significance of YY1 protein expression and mRNA levels by bioinformatics analysis in human cancers: A therapeutic target
Benjamin Bonavida et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer
Philip A. Watson et al.
NATURE REVIEWS CANCER (2015)
High Fidelity Patient-Derived Xenografts for Accelerating Prostate Cancer Discovery and Drug Development
Dong Lin et al.
CANCER RESEARCH (2014)
A Noncanonical Frizzled2 Pathway Regulates Epithelial-Mesenchymal Transition and Metastasis
Taranjit S. Gujral et al.
CELL (2014)
Aggressive Variants of Castration-Resistant Prostate Cancer
Himisha Beltran et al.
CLINICAL CANCER RESEARCH (2014)
Prognostic significance of neuroendocrine components in gastric carcinomas
Ji Y. Park et al.
EUROPEAN JOURNAL OF CANCER (2014)
Yin Yang 1 contributes to gastric carcinogenesis and its nuclear expression correlates with shorter survival in patients with early stage gastric adenocarcinoma
Wei Kang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Tumor-Initiating Cells and FZD8 Play a Major Role in Drug Resistance in Triple-Negative Breast Cancer
Shuping Yin et al.
MOLECULAR CANCER THERAPEUTICS (2013)
microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis
N. Zhang et al.
ONCOGENE (2013)
Yin Yang 1 Plays an Essential Role in Breast Cancer and Negatively Regulates p27
Meimei Wan et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Yin Yang 1 contains G-quadruplex structures in its promoter and 5'-UTR and its expression is modulated by G4 resolvase 1
Weiwei Huang et al.
NUCLEIC ACIDS RESEARCH (2012)
Simple Neurite Tracer: open source software for reconstruction, visualization and analysis of neuronal processes
Mark H. Longair et al.
BIOINFORMATICS (2011)
Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets
Himisha Beltran et al.
CANCER DISCOVERY (2011)
Siah2-Dependent Concerted Activity of HIF and FoxA2 Regulates Formation of Neuroendocrine Phenotype and Neuroendocrine Prostate Tumors
Jianfei Qi et al.
CANCER CELL (2010)
CXCR4/YY1 inhibition impairs VEGF network and angiogenesis during malignancy
Filomena de Nigris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Snail Transcription Factor Regulates Neuroendocrine Differentiation in LNCaP Prostate Cancer Cells
Danielle McKeithen et al.
PROSTATE (2010)
Yin Yang 1 regulates the transcriptional activity of androgen receptor
Z. Deng et al.
ONCOGENE (2009)
Dissociation of epithelial and neuroendocrine carcinoma lineages in the transgenic adenocarcinoma of mouse prostate model of prostate cancer
Teresa Chiaverotti et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
NeuroD1 expression in human prostate cancer: Can it contribute to neuroendocrine differentiation comprehension?
Luca Cindolo et al.
EUROPEAN UROLOGY (2007)
Localization of immunoreactive HIF-1α and HIF-2α in neuroendocrine cells of both benign and malignant prostate glands
Nastaran Monsef et al.
PROSTATE (2007)
Gene function correlates with potential for G4 DNA formation in the human genome
Johanna Eddy et al.
NUCLEIC ACIDS RESEARCH (2006)
Androgen deprivation therapy for prostate cancer
N Sharifi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Promoter features related to tissue specificity as measured by Shannon entropy
J Schug et al.
GENOME BIOLOGY (2005)
Yin Yang 1 is a negative regulator of p53
GC Sui et al.
CELL (2004)
Neuroendocrine differentiation in human prostate cancer. Morphogenesis, proliferation and androgen receptor status
H Bonkhoff
ANNALS OF ONCOLOGY (2001)
分享论文
